Drug Safety News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–2 of 2 articles
Earlier
High impact NewsApr 24, 2026
ImmunityBio (IBRX) Faces FDA Warning Letter and Class Action Lawsuit Over Anktiva Claims
Oncology/Immunotherapy · 3 min
Dr. Sarah MitchellHigh impact NewsApr 16, 2026
FDA Warning Letters: Understanding Pharmaceutical Compliance Actions and Their Impact on Drug Safety
FDA · 3 min
James Chen, PharmDExplore intelligence